Sining Hu Selected Research

Sining Hu Research Topics

Disease

13	Atherosclerotic Plaque (Atheroma) 01/2024 - 09/2012
10	Acute Coronary Syndrome 01/2023 - 09/2012
10	AIDS-Related Complex (ARC) 01/2023 - 09/2013
9	Thrombosis (Thrombus) 01/2023 - 09/2011
8	Atherosclerosis 01/2024 - 01/2012
8	Rupture 01/2023 - 06/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2012
4	Inflammation (Inflammations) 11/2023 - 09/2011
4	ST Elevation Myocardial Infarction 04/2022 - 04/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 04/2022
3	Myocardial Infarction 08/2022 - 03/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 12/2023
2	Stroke (Strokes) 01/2023 - 04/2022
2	Death (Near-Death Experience) 01/2023 - 08/2022
2	Pathologic Constriction (Stenosis) 10/2019 - 03/2017
2	Diabetes Mellitus 01/2018 - 05/2013
2	Stable Angina 12/2016 - 09/2012
2	Hyperplasia 11/2013 - 09/2011
1	Hyperhomocysteinemia 12/2023
1	Hypertension (High Blood Pressure) 10/2023
1	Hypertensive Nephropathy 10/2023
1	MINOCA 01/2023
1	Neoplasms (Cancer) 01/2023
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2023
1	Ischemia 08/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2022
1	Heart Arrest (Cardiac Arrest) 08/2022
1	Heart Failure 04/2022
1	Coronary Disease (Coronary Heart Disease) 04/2017
1	Hemorrhage 03/2017
1	Wounds and Injuries (Trauma) 12/2015
1	Neointima 06/2014
1	Carotid Artery Diseases 01/2013
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2012
1	Hypersensitivity (Allergy) 09/2011

Drug/Important Bio-Agent (IBA)

20	LipidsIBA 12/2023 - 01/2012
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 09/2012
4	Apolipoproteins E (ApoE)IBA 01/2024 - 01/2023
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2022
3	CholesterolIBA 01/2023 - 01/2013
3	Phenobarbital (Luminal)FDA Link 10/2019 - 06/2014
2	CollagenIBA 01/2024 - 12/2023
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 12/2023
2	CytokinesIBA 12/2023 - 04/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2018
2	TicagrelorIBA 12/2017 - 10/2013
2	LipopolysaccharidesIBA 01/2014 - 08/2012
1	tobacco tarIBA 01/2024
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	HomocysteineIBA 12/2023
1	CalciumIBA 12/2023
1	Methionine (L-Methionine)FDA Link 12/2023
1	ApigeninIBA 11/2023
1	InflammasomesIBA 10/2023
1	SaltsIBA 10/2023
1	IronIBA 01/2023
1	ferrostatin-1IBA 01/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	HDL CholesterolIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	CeramidesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017
1	Cystatin CIBA 03/2017
1	CreatinineIBA 03/2017
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 03/2015
1	bivalirudin (Angiomax)FDA Link 03/2015
1	Heparin (Liquaemin)FDA LinkGeneric 03/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2014
1	Atorvastatin (Lipitor)FDA Link 01/2013
1	ferric chlorideIBA 01/2012
1	MetalsIBA 09/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2011
1	Sirolimus (Rapamycin)FDA Link 09/2011
1	FibrinIBA 09/2011
1	PolymersIBA 09/2011

Therapy/Procedure

8	Stents 03/2017 - 09/2011
7	Percutaneous Coronary Intervention 01/2023 - 03/2015
7	Therapeutics 08/2021 - 09/2012
3	Drug-Eluting Stents 03/2017 - 09/2011
1	Patient Readmission 01/2023
1	Secondary Prevention 09/2012